%PDF-1.6
%
1 0 obj
<>]/Pages 2 0 R/Type/Catalog>>
endobj
749 0 obj
<>stream
Adobe Acrobat 9.55 Paper Capture Plug-in
2013-06-26T09:39:56-04:00
2013-09-12T18:12:45-04:00
ScandAll PRO V1.8 Update1
2013-09-12T18:12:45-04:00
uuid:74d6bcc6-8fa4-4138-a0ab-49ee578a9dfb
uuid:3259353c-3b4a-4b6a-94ed-6d70fbb423d1
application/pdf
1
B
http://ns.adobe.com/pdf/1.3/
pdf
Adobe PDF Schema
internal
A name object indicating whether the document has been modified to include trapping information
Trapped
Text
http://ns.adobe.com/xap/1.0/mm/
xmpMM
XMP Media Management Schema
internal
UUID based identifier for specific incarnation of a document
InstanceID
URI
http://www.aiim.org/pdfa/ns/id/
pdfaid
PDF/A ID Schema
internal
Part of PDF/A standard
part
Integer
internal
Amendment of PDF/A standard
amd
Text
internal
Conformance level of PDF/A standard
conformance
Text
endstream
endobj
4186 0 obj
<>
endobj
2 0 obj
<>
endobj
172 0 obj
<>
endobj
171 0 obj
<>
endobj
253 0 obj
<>
endobj
334 0 obj
<>
endobj
415 0 obj
<>
endobj
496 0 obj
<>
endobj
577 0 obj
<>
endobj
658 0 obj
<>
endobj
739 0 obj
<>
endobj
671 0 obj
<>
endobj
687 0 obj
<>
endobj
703 0 obj
<>
endobj
719 0 obj
<>
endobj
735 0 obj
<>
endobj
716 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Type/Page>>
endobj
720 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Type/Page>>
endobj
723 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/Type/Page>>
endobj
726 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI]/XObject<>>>/Type/Page>>
endobj
729 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI]/XObject<>>>/Type/Page>>
endobj
732 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI]/XObject<>>>/Type/Page>>
endobj
736 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Type/Page>>
endobj
740 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI]/XObject<>>>/Type/Page>>
endobj
743 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/Type/Page>>
endobj
746 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Type/Page>>
endobj
4197 0 obj
<>stream
BT
/CS0 cs 0.2 0.188 0.204 scn
/T1_0 1 Tf
-0.0061 Tc 3 Tr 11.6 0 0 11.6 523.13 745.92 Tm
(217 )Tj
-0.0194 Tc -35.335 -3.124 Td
([20] )Tj
0.0002 Tc 3.002 0 Td
(A.R. )Tj
0.0123 Tc 2.254 0 Td
(Yaya, )Tj
-0.0319 Tc 2.729 0 Td
(M. )Tj
0.0158 Tc 1.485 0 Td
(Touaibia, )Tj
-0.035 Tc 11.454 0 0 11.6 272.52 709.68 Tm
(G. )Tj
0.0149 Tc 11.6 0 0 11.6 287.71 709.68 Tm
(Massarweh, )Tj
-0.0007 Tc 5.276 0 Td
(F.D. )Tj
0.013 Tc 2.131 0 Td
(Rochon, )Tj
/T1_1 1 Tf
-0.0003 Tc 11.4 0 0 11.4 417.35 709.68 Tm
(L. )Tj
/T1_0 1 Tf
0.0194 Tc 11.6 0 0 11.6 430.99 709.68 Tm
(Breau, )Tj
0.0103 Tc 3.069 0 Td
(Synthe )Tj
-0.0183 Tc 2.88 0 Td
(sis )Tj
0.05 Tc 12.5203 0 0 11.6 515.64 709.68 Tm
(of )Tj
-0.035 Tc 11.0117 0 0 11.6 529.78 709.68 Tm
(17 )Tj
0.029 Tc 11.6 0 0 11.6 148.44 694.57 Tm
(a-substituted )Tj
0.0276 Tc 6.062 0 Td
(ethynylestradiols: )Tj
0.0144 Tc 8.226 0 Td
(potential )Tj
0.0112 Tc 4.231 0 Td
(ligands )Tj
-0.0029 Tc 3.577 0 Td
(for )Tj
0.0058 Tc 1.802 0 Td
(drug )Tj
0.263 0.255 0.267 scn
0.0111 Tc 2.47 0 Td
(vectors, )Tj
0.2 0.188 0.204 scn
-0.0018 Tc 3.873 0 Td
(Steroids. )Tj
-0.0237 Tc -30.261 -1.2 Td
(75 )Tj
0.263 0.255 0.267 scn
0.0085 Tc 1.302 0 Td
(\(2010\) )Tj
0.2 0.188 0.204 scn
0.0076 Tc 3.008 0 Td
(489-498. )Tj
-0.0194 Tc -7.323 -3.022 Td
([21] )Tj
-0.0014 Tc 3.014 0 Td
(C.N. )Tj
0.018 Tc 2.787 0 Td
(N'Soukpoe-Kossi, )Tj
-0.035 Tc 11.4499 0 0 11.6 278.52 645.6 Tm
(C. )Tj
0.0176 Tc 11.6 0 0 11.6 299.23 645.6 Tm
(Descoteaux, )Tj
/T1_1 1 Tf
-0.035 Tc 10.7822 0 0 11.4 368.39 645.6 Tm
(E. )Tj
/T1_0 1 Tf
0.0099 Tc 11.6 0 0 11.6 388.78 645.6 Tm
(Asselin, )Tj
0 Tc 4.214 0 Td
(l )Tj
0.0151 Tc 1.515 0 Td
(Bariyanga, )Tj
-0.0167 Tc 5.379 0 Td
(H.A. )Tj
0.0134 Tc -31.846 -1.2 Td
(Tajmir-Riahi, )Tj
-0.035 Tc 11.454 0 0 11.6 222.6 631.68 Tm
(G. )Tj
0.019 Tc 11.6 0 0 11.6 242.83 631.68 Tm
(Berube, )Tj
0.0184 Tc 4.03 0 Td
(Transfer )Tj
0.022 Tc 4.246 0 Td
(RNA )Tj
0.0149 Tc 2.902 0 Td
(bindings )Tj
-0.0091 Tc 4.321 0 Td
(to )Tj
0.0176 Tc 1.544 0 Td
(antitumor )Tj
0.0061 Tc 4.779 0 Td
(estradiol\255)Tj
0.0158 Tc -30.009 -1.22 Td
(platinum\(II\) )Tj
0.0208 Tc 5.334 0 Td
(hybrid )Tj
0.0289 Tc 2.991 0 Td
(and )Tj
0.0124 Tc 1.759 0 Td
(cisplatin, )Tj
0.0322 Tc 4.04 0 Td
(DNA )Tj
-0.0022 Tc 2.497 0 Td
(Cell. )Tj
0.0043 Tc 2.241 0 Td
(Biol. )Tj
0.263 0.255 0.267 scn
-0.0087 Tc 2.316 0 Td
(27 )Tj
0.2 0.188 0.204 scn
0.0085 Tc 1.298 0 Td
(\(2008\) )Tj
0.0077 Tc 3.021 0 Td
(337-343. )Tj
-0.0194 Tc -28.481 -3.001 Td
([22] )Tj
-0.0014 Tc 3.014 0 Td
(C.N. )Tj
0.018 Tc 2.828 0 Td
(N'Soukpoe-Kossi, )Tj
-0.035 Tc 11.4499 0 0 11.6 279.72 582.72 Tm
(C. )Tj
0.0155 Tc 11.6 0 0 11.6 301.15 582.72 Tm
(Descoteaux, )Tj
-0.035 Tc 11.2295 0 0 11.6 370.98 582.72 Tm
(E. )Tj
0.0099 Tc 11.6 0 0 11.6 391.66 582.72 Tm
(Asselin, )Tj
0.004 Tc 4.28 0 Td
(H.A. )Tj
0.0082 Tc 2.954 0 Td
(Tajmir-Riahi, )Tj
-0.035 Tc 11.454 0 0 11.6 148.44 568.8 Tm
(G. )Tj
0.0156 Tc 11.6 0 0 11.6 162.91 568.8 Tm
(Berube, )Tj
0.0425 Tc 3.641 0 Td
(DNA )Tj
0.0174 Tc 2.665 0 Td
(interaction )Tj
0.0233 Tc 4.848 0 Td
(with )Tj
0.0148 Tc 2.234 0 Td
(novel )Tj
0.263 0.255 0.267 scn
0.015 Tc 2.722 0 Td
(antitumor )Tj
0.2 0.188 0.204 scn
0.0124 Tc 4.428 0 Td
(estradiol-platinum\(II\) )Tj
0.0126 Tc 9.34 0 Td
(hybrid )Tj
0.0187 Tc -31.159 -1.22 Td
(molecule )Tj
0.263 0.255 0.267 scn
0 Tc 4.115 0 Td
(: )Tj
0.2 0.188 0.204 scn
0.635 0 Td
(a )Tj
0.0153 Tc 0.828 0 Td
(comparative )Tj
0.0183 Tc 5.499 0 Td
(study )Tj
0.0233 Tc 2.619 0 Td
(with )Tj
0.0141 Tc 2.227 0 Td
(cisplatin )Tj
-0.0013 Tc 3.89 0 Td
(drug, )Tj
0.05 Tc 11.6296 0 0 11.6 406.75 554.65 Tm
(DNA )Tj
0.003 Tc 11.6 0 0 11.6 437.4 554.65 Tm
(Cell. )Tj
0.0043 Tc 2.344 0 Td
(Biol. )Tj
0.263 0.255 0.267 scn
-0.0087 Tc 2.44 0 Td
(27 )Tj
0.0002 Tc 1.4 0 Td
(\(2008\) )Tj
0.2 0.188 0.204 scn
0.0008 Tc -31.036 -1.201 Td
(101-107. )Tj
-0.0194 Tc -3.093 -2.999 Td
([23] )Tj
/T1_1 1 Tf
-0.035 Tc 10.7822 0 0 11.4 148.07 505.93 Tm
(E. )Tj
/T1_0 1 Tf
0.0131 Tc 11.6 0 0 11.6 164.83 505.93 Tm
(Froehlich, )Tj
-0.0145 Tc 4.741 0 Td
(A. )Tj
0.015 Tc 1.564 0 Td
(Gupta, )Tj
-0.035 Tc 11.278 0 0 11.6 276.66 505.93 Tm
(J. )Tj
0.0145 Tc 11.6 0 0 11.6 290.59 505.93 Tm
(Provencher-Mandeville, )Tj
/T1_1 1 Tf
-0.035 Tc 11.0587 0 0 11.4 412.78 505.93 Tm
(E. )Tj
/T1_0 1 Tf
0.0128 Tc 11.6 0 0 11.6 429.58 505.93 Tm
(Asselin, )Tj
-0.035 Tc 11.278 0 0 11.6 474.9 505.93 Tm
(J. )Tj
0.0105 Tc 11.6 0 0 11.6 488.83 505.93 Tm
(Bariyanga, )Tj
-0.035 Tc 11.454 0 0 11.6 148.2 491.77 Tm
(G. )Tj
0.0156 Tc 11.6 0 0 11.6 162.91 491.77 Tm
(Berube, )Tj
0.004 Tc 3.703 0 Td
(H.A. )Tj
0.0151 Tc 2.499 0 Td
(Tajmir-Riahi, )Tj
0.015 Tc 6.177 0 Td
(Study )Tj
0.05 Tc 12.7985 0 0 11.6 339.72 491.77 Tm
(of )Tj
0.0322 Tc 11.6 0 0 11.6 354.91 491.77 Tm
(DNA )Tj
0.0128 Tc 2.708 0 Td
(Interactions )Tj
0.0233 Tc 5.343 0 Td
(with )Tj
0.0113 Tc 2.342 0 Td
(Steroidal )Tj
0.0082 Tc 4.146 0 Td
(and )Tj
0.018 Tc -32.385 -1.2 Td
(Nonsteroidal )Tj
0.0175 Tc 5.803 0 Td
(Estrogen-Platinum )Tj
0.0148 Tc 8.208 0 Td
(\(II\)-Based )Tj
0.0173 Tc 4.645 0 Td
(Anticancer )Tj
0.0149 Tc 4.942 0 Td
(Drugs, )Tj
0.0425 Tc 3.207 0 Td
(DNA )Tj
-0.0073 Tc 2.684 0 Td
(Cell. )Tj
-0.0061 Tc 2.344 0 Td
(Biol. )Tj
-0.0087 Tc -31.802 -1.2 Td
(28 )Tj
0.0085 Tc 1.318 0 Td
(\(2009\) )Tj
0.0039 Tc 3.021 0 Td
(31-39. )Tj
-0.0125 Tc -7.357 -3.021 Td
([24] )Tj
-0.035 Tc 11.4499 0 0 11.6 148.44 428.89 Tm
(C. )Tj
0.0294 Tc 11.6 0 0 11.6 167.25 428.89 Tm
(V\340n )Tj
0.0137 Tc 2.415 0 Td
(Themsche, )Tj
-0.035 Tc 11.0802 0 0 11.6 255.88 428.89 Tm
(S. )Tj
0.0149 Tc 11.6 0 0 11.6 273.07 428.89 Tm
(Parent, )Tj
-0.0137 Tc 3.602 0 Td
(V. )Tj
0.012 Tc 1.715 0 Td
(Leblanc, )Tj
-0.035 Tc 11.4499 0 0 11.6 384.36 428.89 Tm
(C. )Tj
0.0155 Tc 11.6 0 0 11.6 403.15 428.89 Tm
(Descoteaux, )Tj
0.0017 Tc 5.775 0 Td
(A.M. )Tj
0.0003 Tc 2.901 0 Td
(Simard, )Tj
-0.035 Tc 11.454 0 0 11.6 148.44 414.96 Tm
(G. )Tj
0.0156 Tc 11.6 0 0 11.6 162.91 414.96 Tm
(Berube, )Tj
0.263 0.255 0.267 scn
-0.035 Tc 11.525 0 0 11.6 207.77 414.96 Tm
(E. )Tj
0.2 0.188 0.204 scn
0.0158 Tc 11.6 0 0 11.6 224.86 414.96 Tm
(Asselin, )Tj
0.0168 Tc 3.992 0 Td
(VP-128, )Tj
0 Tc 4.109 0 Td
(a )Tj
0.02 Tc 1.043 0 Td
(novel )Tj
0.0136 Tc 2.93 0 Td
(oestradiol-platinum\(II\) )Tj
0.0167 Tc 10.063 0 Td
(hybrid )Tj
0.263 0.255 0.267 scn
0.0095 Tc 3.29 0 Td
(with )Tj
0.2 0.188 0.204 scn
0.0141 Tc -32.019 -1.221 Td
(selective )Tj
0.0156 Tc 3.976 0 Td
(anti-tumour )Tj
0.0172 Tc 5.234 0 Td
(activity )Tj
0.0144 Tc 3.463 0 Td
(towards )Tj
0.018 Tc 3.622 0 Td
(hormone-dependent )Tj
0.0256 Tc 8.609 0 Td
(breast )Tj
0.263 0.255 0.267 scn
0.0209 Tc 2.866 0 Td
(cancer )Tj
0.0029 Tc 3.041 0 Td
(cells )Tj
0.2 0.188 0.204 scn
-0.016 Tc 2.235 0 Td
(in )Tj
0.0067 Tc -33.055 -1.199 Td
(vivo, )Tj
0.0071 Tc 2.354 0 Td
(Endocr. )Tj
0.0051 Tc 3.498 0 Td
(Relat. )Tj
0.0078 Tc 2.746 0 Td
(Cancer. )Tj
-0.035 Tc 11.5489 0 0 11.6 288.8 386.89 Tm
(16 )Tj
0.0126 Tc 11.6 0 0 11.6 303.22 386.89 Tm
(\(2009\) )Tj
0.0045 Tc 3.081 0 Td
(1185-1195. )Tj
-0.0194 Tc -19.459 -3.001 Td
([25] )Tj
-0.035 Tc 11.278 0 0 11.6 148.26 352.08 Tm
(J. )Tj
0.0135 Tc 11.6 0 0 11.6 159 352.08 Tm
(Carmichael, )Tj
0 Tc 5.283 0 Td
(W)Tj
0.349 0.349 0.353 scn
1.017 0 Td
(.)Tj
0.2 0.188 0.204 scn
0.238 0 Td
(G)Tj
0.349 0.349 0.353 scn
0.776 0 Td
(. )Tj
0.2 0.188 0.204 scn
0.0172 Tc 0.472 0 Td
(DeGraff, )Tj
0.0024 Tc 3.996 0 Td
(A.F. )Tj
0.0078 Tc 2.143 0 Td
(Gazdar, )Tj
0.05 Tc 13.6758 0 0 11.6 361.08 352.08 Tm
(lD. )Tj
0.0138 Tc 11.6 0 0 11.6 383.23 352.08 Tm
(Minna, )Tj
0.05 Tc 15.4641 0 0 11.6 420.59 352.08 Tm
(lB)Tj
0.349 0.349 0.353 scn
0 Tc 11.6 0 0 11.6 436.8 352.08 Tm
(. )Tj
0.2 0.188 0.204 scn
0.0127 Tc 0.492 0 Td
(Mitchell, )Tj
0.0126 Tc 4.033 0 Td
(Evaluation )Tj
0.05 Tc 12.7985 0 0 11.6 148.2 338.17 Tm
(of )Tj
0 Tc 11.6 0 0 11.6 167.4 338.17 Tm
(a )Tj
0.0172 Tc 1.249 0 Td
[(tetrazolium-based )-519(semiautomated )]TJ
0.0115 Tc 15.303 0 Td
(colorimetrie )Tj
0.05 Tc 11.6421 0 0 11.6 427.08 338.17 Tm
(assay: )Tj
0.0138 Tc 11.6 0 0 11.6 468.84 338.17 Tm
(assessment )Tj
0.05 Tc 12.5203 0 0 11.6 530.76 338.17 Tm
(of )Tj
0.0163 Tc 11.6 0 0 11.6 148.45 324 Tm
(chemosensitivity )Tj
0.0098 Tc 7.269 0 Td
(testing, )Tj
0.0263 Tc 3.282 0 Td
(Cancer )Tj
-0.0026 Tc 3.213 0 Td
(Res. )Tj
0.0084 Tc 2.048 0 Td
(47 )Tj
0.0126 Tc 1.316 0 Td
(\(1987\) )Tj
0.0089 Tc 3.022 0 Td
(936-942. )Tj
-0.0194 Tc -23.185 -3.021 Td
([26] )Tj
-0.0015 Tc 3.02 0 Td
(R.M. )Tj
0.0121 Tc 2.647 0 Td
(Eglen, )Tj
0.0183 Tc 3.207 0 Td
(Enzyme )Tj
0.0141 Tc 3.926 0 Td
(fragment )Tj
0.0268 Tc 4.284 0 Td
(complementation: )Tj
0 Tc 8.234 0 Td
(a )Tj
0.0108 Tc 0.972 0 Td
(flexible )Tj
0.0228 Tc 3.692 0 Td
(high )Tj
0.0117 Tc 2.378 0 Td
(throughput )Tj
0.0134 Tc -29.328 -1.199 Td
(screening )Tj
0.0152 Tc 4.224 0 Td
(assay )Tj
0.0154 Tc 2.491 0 Td
(technology, )Tj
0.0269 Tc 5.132 0 Td
(Assay )Tj
0.024 Tc 2.811 0 Td
(Drug )Tj
0.0017 Tc 2.379 0 Td
(Dev. )Tj
0.0045 Tc 2.251 0 Td
(Technol. )Tj
0 Tc 3.967 0 Td
(1 )Tj
0.0085 Tc 0.725 0 Td
(\(2002\) )Tj
0.0076 Tc 3.022 0 Td
(97-104. )Tj
ET
q
/CS0 cs 0.159 0.159 0.159 scn
449.2799988 0 0 721.9199982 107.5200043 30.4559937 cm
/Im0 Do
Q
endstream
endobj
2811 0 obj
<>/Filter/JBIG2Decode/Height 3008/ImageMask true/Length 3163/Subtype/Image/Width 1872>>stream
0 P @ 1 P n^УVLo/'?m-ky@3Ա%_І|$\hw.5ވtE0$R/&gNKˣ+XuBׄ?8h1K2vE@NQcf QWx9Z28[Ŧ1IINqe]:6ܸޱRнL#